Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study.
Mallah N, Visos-Varela I, Takkouche B, Bugarín-González R, Piñeiro-Lamas M, Herdeiro T, Zapata-Cachafeiro M, Rodríguez-Fernández A, Salgado-Barreira A, Figueiras A; COVIDrug Group. Mallah N, et al. Among authors: bugarin gonzalez r. Inflammopharmacology. 2024 Dec;32(6):3697-3705. doi: 10.1007/s10787-024-01568-y. Epub 2024 Sep 23. Inflammopharmacology. 2024. PMID: 39312097 Free PMC article.
Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.
Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodríguez S, Bugarín-González R, González-Barcala FJ, Herdeiro MT, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á. Visos-Varela I, et al. Among authors: bugarin gonzalez r. J Med Virol. 2023 Jul;95(7):e28971. doi: 10.1002/jmv.28971. J Med Virol. 2023. PMID: 37486310
Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient.
García-Álvarez RM, Zapata-Cachafeiro M, Visos-Varela I, Rodríguez-Fernández A, Pintos-Rodríguez S, Piñeiro-Lamas M, Herdeiro TM, Figueiras A, Salgado-Barreira A; COVID-Drug Group. García-Álvarez RM, et al. Inflammopharmacology. 2024 Jun;32(3):1805-1815. doi: 10.1007/s10787-024-01475-2. Epub 2024 Apr 15. Inflammopharmacology. 2024. PMID: 38619761 Free PMC article.
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study.
Rodríguez-Fernández A, Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodríguez S, García-Álvarez RM, Herdeiro TM, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á; COVIDRUG Group. Rodríguez-Fernández A, et al. Inflammopharmacology. 2024 Aug;32(4):2305-2315. doi: 10.1007/s10787-024-01474-3. Epub 2024 May 2. Inflammopharmacology. 2024. PMID: 38698179 Free PMC article.
[Parsonage-Turner syndrome in relation to fifth disease].
Bugarín González R, Docasar Barrera AI, Hernández Dorta S, Villar Carballo JA, Castillo Riera A. Bugarín González R, et al. Semergen. 2024 Dec 16;51(5):102426. doi: 10.1016/j.semerg.2024.102426. Online ahead of print. Semergen. 2024. PMID: 39689505 Spanish. No abstract available.
[About the crisis in Primary Care].
Bugarín González R. Bugarín González R. Semergen. 2023 Mar;49(2):101843. doi: 10.1016/j.semerg.2022.101843. Epub 2022 Oct 3. Semergen. 2023. PMID: 36201987 Spanish. No abstract available.
[Ethics Committee experience during COVID-19 emergency. A brief report.].
Bugarín González R, Romero-Yuste SM, López Vázquez PM, Casariego Rosón J, Carballeda Feijóo N, Cruz Del Río JM, Cueva Bañuelos JF, Fernández Rial JÁ, Fernández Trisac JL, Ferreira Díaz MJ, Millán Calenti RÁ, Pía Morandeira A, Prado Casal J, Rodríguez-Tenreiro Sánchez C, Santos García D, Vázquez Lago JM, Verdejo González MA, Zarra Ferro I. Bugarín González R, et al. Rev Esp Salud Publica. 2020 Nov 3;94:e202011146. Rev Esp Salud Publica. 2020. PMID: 33140740 Free PMC article. Spanish.
35 results